NEMRX
Price
$25.33
Change
-$0.07 (-0.28%)
Updated
Nov 19 closing price
Net Assets
222.07M
VEIEX
Price
$34.03
Change
-$0.05 (-0.15%)
Updated
Nov 19 closing price
Net Assets
141.19B
Interact to see
Advertisement

NEMRX vs VEIEX

Header iconNEMRX vs VEIEX Comparison
Open Charts NEMRX vs VEIEXBanner chart's image
Neuberger Berman Emerg Mkts Eq R3
Price$25.33
Change-$0.07 (-0.28%)
VolumeN/A
Net Assets222.07M
Vanguard Emerging Mkts Stock Idx I
Price$34.03
Change-$0.05 (-0.15%)
VolumeN/A
Net Assets141.19B
NEMRX vs VEIEX Comparison Chart in %
View a ticker or compare two or three
VS
NEMRX vs. VEIEX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEMRX is a Hold and VEIEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 141B vs. NEMRX (222M). VEIEX pays higher dividends than NEMRX: VEIEX (2.61) vs NEMRX (0.00). NEMRX was incepted earlier than VEIEX: NEMRX (15 years) vs VEIEX (32 years). NEMRX (2.25) is less costly to investors than VEIEX (0.29). NEMRX is a more actively managed with annual turnover of: 111.00 vs. VEIEX (8.00). NEMRX (0) and VEIEX (0) have matching initial minimum investment requirements. NEMRX annual gain was more profitable for investors over the last year : 29.39 vs. VEIEX (20.18). VEIEX return over 5 years is better than : 23.38 vs. NEMRX (17.27).
NEMRXVEIEXNEMRX / VEIEX
Total Expense Ratio1.950.29672%
Annual Report Gross Expense Ratio2.250.29776%
Fund Existence15 years32 years-
Gain YTD30.52422.205137%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets222M141B0%
Annual Yield % from dividends0.002.61-
Returns for 1 year29.3920.18146%
Returns for 3 years52.4047.23111%
Returns for 5 years17.2723.3874%
Returns for 10 years75.4878.6196%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUE0.58N/A
+0.02%
Cue Biopharma
RNGR13.51N/A
N/A
Ranger Energy Services
MTSR70.50N/A
N/A
Metsera Inc
CHPGU10.26N/A
N/A
Championsgate Acquisition Corp
TRVI11.05-0.26
-2.30%
Trevi Therapeutics